Cofactors

Biotin Water® Hair, Skin, & Nails Makes Its Way To Publix Supermarkets

Friday, June 11, 2021 - 1:44pm

ROME, Ga., June 11, 2021 /PRNewswire/ --2T Water, LLC, the maker of Biotin Water Hair, Skin, and Nails announced today that Biotin Water will be sold at Publix Supermarkets across the southeast region of the United States starting June 2021.

Key Points: 
  • ROME, Ga., June 11, 2021 /PRNewswire/ --2T Water, LLC, the maker of Biotin Water Hair, Skin, and Nails announced today that Biotin Water will be sold at Publix Supermarkets across the southeast region of the United States starting June 2021.
  • 2T Water, LLC owns the exclusive rights to distribute Biotin Water Hair, Skin, and Nails which is the first biotin infused beverage that delivers 300 mcg per 16oz with zinc and folic acid included in the proprietary formula.
  • Biotin Water Hair, Skin, and Nails is formulated to ensure the body is properly hydrated while enjoying the many benefits of B7, often considered the most overlooked vitamin.
  • This new introduction of Biotin Water gives consumers more locations throughout the southeast to purchase Biotin Water in a great grocery chain.

Global Biotin Supplements Market (2020 to 2026) - Industry Analysis, Trends, Market Size, and Forecasts - ResearchAndMarkets.com

Tuesday, March 23, 2021 - 9:16am

The "Biotin Supplements Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Biotin Supplements Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering.
  • The report on the global biotin supplements market provides qualitative and quantitative analysis for the period from 2018 to 2026.
  • The report predicts the global biotin supplements market to grow with a healthy CAGR over the forecast period from 2020-2026.
  • The report on biotin supplements market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global biotin supplements market over the period of 2018 to 2026.

Global Hemophilia A Market to 2030 - Insights, Epidemiology and Forecast - ResearchAndMarkets.com

Thursday, March 11, 2021 - 3:03pm

The "Hemophilia A - Market Insights, Epidemiology, and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hemophilia A - Market Insights, Epidemiology, and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The Hemophilia A market report provides current treatment practices, emerging drugs, Hemophilia A market share of the individual therapies, current and forecasted Hemophilia A market size from 2018 to 2030 segmented by seven major markets.
  • The current market for Hemophilia A includes Recombinant factor VIII (short and long-acting), Plasma-derived products, bypassing agents, bi-specific antibody, and a few others.
  • To understand the future market competition in the Hemophilia A market and Insightful review of the key market drivers and barriers.

FDA Approves First Treatment for Molybdenum Cofactor Deficiency Type A

Friday, February 26, 2021 - 11:10pm

Patients with Molybdenum Cofactor Deficiency Type A experience severe and rapidly progressive neurologic damage including intractable seizures, feeding difficulties and muscle weakness from the accumulation of toxic sulfite metabolites in the central nervous system.

Key Points: 
  • Patients with Molybdenum Cofactor Deficiency Type A experience severe and rapidly progressive neurologic damage including intractable seizures, feeding difficulties and muscle weakness from the accumulation of toxic sulfite metabolites in the central nervous system.
  • Before today's approval, the only treatment options included supportive care and therapies directed towards the complications arising from the disease.
  • Patients with Molybdenum Cofactor Deficiency Type A cannot produce a substance known as cyclic pyranopterin monophosphate (cPMP).
  • The effectiveness of Nulibry for the treatment of Molybdenum Cofactor Deficiency Type A was demonstrated in 13 treated patients compared to 18 matched, untreated patients.

Data at EAHAD 2021 Highlight Value of Takeda’s Leading Hematology Portfolio in Clinical Settings and Commitment to Patient-Focused Advancements

Wednesday, February 3, 2021 - 8:00am

No shares or other securities are being offered to the public by means of this press release.

Key Points: 
  • No shares or other securities are being offered to the public by means of this press release.
  • Any failure to comply with these restrictions may constitute a violation of applicable securities laws.
  • In this press release, Takeda is sometimes used for convenience where references are made to Takeda and its subsidiaries in general.
  • Real world Bleeding Rates over 7 Years of Antihemophilic Factor (recombinant) in Patients with Hemophilia A and Target Joints: AHEAD International
    3 EAHAD 2021.

Bloom Beauty Essence® – Skincare Supplement and Beverage Packed with Superfood to Make Your Skin Radiant

Thursday, January 28, 2021 - 5:30pm

BOCA RATON, FL, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Bloom Beauty Essence offers skincare supplements and beverages with collagen that will make your skin radiant and firmer.

Key Points: 
  • BOCA RATON, FL, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Bloom Beauty Essence offers skincare supplements and beverages with collagen that will make your skin radiant and firmer.
  • For our skincare beverage, Bloom Beauty used natural antioxidants, vitamin B-3, aloe vera, biotin, and a high-quality collagen complex with high bioavailability.
  • Bloom Beauty Essence provides the needed nutrients people need for beautiful and firmer skin.
  • Steiner-Kinezler said Bloom Beauty Essence Skin Care Drink provides the skin with needed moisture and reduces the appearance of wrinkles.

Worldwide Industry for Methylcobalamin to 2025 - Impact of COVID-19

Thursday, November 5, 2020 - 7:15pm

This report is a professional and in-depth study on the current state of the global Methylcobalamin market with a focus on the Chinese market.

Key Points: 
  • This report is a professional and in-depth study on the current state of the global Methylcobalamin market with a focus on the Chinese market.
  • It is a valuable source of guidance and direction for companies and individuals interested in Methylcobalamin industry.
  • The global Methylcobalamin market is further divided by company, by country, and by application/type for the competitive landscape analysis.
  • Overall, the report provides an in-depth insight of 2015-2025 global and Chinese Methylcobalamin market covering all important parameters.

Methylcobalamin Market Insights (2020 to 2025) - Analysis and Forecast for the Global and Chinese Markets - ResearchAndMarkets.com

Monday, November 2, 2020 - 11:18am

The report explores Global and Chinese major players in Methylcobalamin market.

Key Points: 
  • The report explores Global and Chinese major players in Methylcobalamin market.
  • The report depicts the global and Chinese total Methylcobalamin market including: capacity, production, production value, cost/profit, supply/demand and Chinese import/export, by statistical analysis.
  • The global Methylcobalamin market is further divided by company, by country, and by application/type for the competitive landscape analysis.
  • Overall, the report provides an in-depth insight of 2015-2025 global and Chinese Methylcobalamin market covering all important parameters.

Octapharma announces FDA approval of updated NUWIQ® Prescribing Information to include immunogenicity data in previously untreated patients

Monday, October 19, 2020 - 4:29pm

Octapharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved an updated Prescribing Information (PI) for NUWIQ, Octapharmas human cell line-derived recombinant factor VIII (FVIII).

Key Points: 
  • Octapharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved an updated Prescribing Information (PI) for NUWIQ, Octapharmas human cell line-derived recombinant factor VIII (FVIII).
  • The updated PI includes immunogenicity data from the NuProtect study in previously untreated patients (PUPs).
  • FVIII inhibitor development is the most serious treatment complication in previously untreated patients (PUPs) with severe haemophilia A.
  • The updated NUWIQ PI includes data from the NuProtect study, which was the largest prospective study of a single FVIII product in true PUPs.

Outlook on the Worldwide Heme Industry to 2025 - Featuring Sichuan Deebio & Impossible Foods

Tuesday, June 23, 2020 - 1:45pm

This report is a professional and in-depth study on the current state of the global Heme market with a focus on the Chinese market.

Key Points: 
  • This report is a professional and in-depth study on the current state of the global Heme market with a focus on the Chinese market.
  • Key points of Heme Market Report:
    The report provides a basic overview of Heme industry including: definition, applications and manufacturing technology.
  • The global Heme market is further divided by company, by country, and by application/type for the competitive landscape analysis.
  • Overall, the report provides an in-depth insight of the 2015-2025 global and Chinese Heme market covering all important parameters.